Biotechs/Pharma research

Sup guys,

I am currently on a quest to find public biotech/pharma companies for investment in Q4 22-Q1 23.

Idea is to find tickers that the BIG guys (read Pfizer, Astra etc.) will be keen on acquiring or investing a noticeable amount of cash in the "near future".

Problem: it is almost impossible to find relevant/valuable info via search engines. Where is this shit situated? If anyone has any thoughts on the topic, do share.

Safe, peace out.

2 Comments
 

Sint repudiandae aut provident laudantium rerum maxime maiores minus. Molestiae error corrupti culpa deleniti nobis ea distinctio. Qui excepturi soluta sed maiores inventore incidunt sed.

Nostrum tempora nisi dolores dolores et. Distinctio debitis dolorum quam vel aut sit. Quas tenetur est corporis magni ipsam quia sit laboriosam. Officiis iusto aliquam quod minus. Aut praesentium mollitia officiis cum autem et.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • JPMorgan 01 98.2%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 01 98.8%
  • Evercore 01 98.2%
  • BMO Capital Markets 12 97.6%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.8%
  • Morgan Stanley 05 98.2%
  • JPMorgan No 97.7%
  • BMO Capital Markets 12 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (43) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (75) $151
  • Intern/Summer Analyst (68) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”